Emerging Technology Reports

The Emerging Technology Report provides regular updates about emerging and potentially disruptive technologies that are likely to have a significant impact in healthcare. This “early warning” report monitors new health technologies from 6 months to 2 years within a regulatory submission and tracks those as they go through clinical trial development and the regulatory approval process.

For each emerging technology, our analysts describe the technology and intended use, its prospects relative to the regulatory process and FDA information, competing technologies, relevant clinical guidelines, high-level look at the evidence such as published abstracts in the medical literature and available meeting abstracts, and available clinical trials.

Vibrant System (Vibrant Gastro Inc.) for Chronic Idiopathic Constipation

The Vibrant vibrating capsule is an electric swallowable capsule that naturally passes through the gastrointestinal tract. It is indicated for the treatment of adults with chronic idiopathic constipation who have not experienced relief of their bowel symptoms by using laxative therapies at the recommended dosage for at least 1 month.

TOPS System (Premia Spine) for Lumbar Spondylolisthesis With Spinal Stenosis

The TOPS System (Premia Spine) is a motion-preserving spinal implant indicated for patients between 35 and 80 years of age with symptomatic degenerative spondylolisthesis up to Grade I, with moderate to severe lumbar spinal stenosis and either the thickening of the ligamentum flavum and/or of the scarring facet joint capsule at one level from L3 to L5.

Detour System (Endologix LLC) for Percutaneous Femoropopliteal Bypass

The Detour System is an endovascular stent-graft bypass system indicated for percutaneous revascularization in patients with symptomatic long femoropopliteal lesions with chronic total occlusion or diffuse stenosis who are suboptimal candidates for surgical or other endovascular treatments.